Related Articles
Controlling serum uric acid using febuxostat in cancer patients at risk of tumor lysis syndrome
Analysis of the incidence of tumor lysis syndrome in patients with hematological malignancies treated with rasburicase
Pharmacokinetics and pharmacodynamics of febuxostat under fasting conditions in healthy individuals
Effect of rosuvastatin on hyperuricemic rats and the protective effect on endothelial dysfunction
FEC (FLUOROURACIL, EPIRUBICIN, CYCLOPHOSPHAMIDE) PLUS GRANULOCYTE MACROPHAGE-COLONY-STIMULATING FACTOR (GM-CSF) IN ADVANCED OR INFLAMMATORY BREAST-CANCER - A DOSE-FINDING STUDY